NCT06434792View on ClinicalTrials.gov

Study to Evaluate Efficacy and Safety of Bronpass Tab. in Patients With Chronic Obstructive Pulmonary Disease

PHASE2RecruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

March 31, 2025

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Bronpass Tab.

Twice daily for 12 weeks

OTHER

Placebo

Twice daily for 12 weeks

Trial Locations (1)

05030

RECRUITING

Konkuk University School of Medicine, Seoul

All Listed Sponsors
lead

Hanlim Pharm. Co., Ltd.

INDUSTRY